4^th Annual Conference on Gynecologic Oncology, Reproductive Disorders, Maternal-Fetal Medicine & Obstetrics July 18-19, 2018 Atlanta, Georgia, USA

Samir A.Farghaly is a physician / Scientist- faculty member at the Medical College of Cornell University, and the New York Presbyterian Hospital/ Cornell University Medical Center, New York, NY – USA. He received his M.D degree from University College, London University and his PhD degree in molecular biology from London University. He was affiliated with Columbia University College of Physicians and surgeons/ Columbia University medical center, New York, NY. He received several clinical and research awards. He has been an invited speaker in several national and international conferences on Women’s health, Molecular genetic of female cancers, Gynecological cancer and Oncology. He is a member of several national and international societies, organizations, foundations of Women health and Cancer. He is an editor, member of editorial boards, editorial advisory boards and reviewers of several medical journals of Cancer Science & Therapy, Gynecology, Gynecological Cancer, Ovary Research, Genomics, Clinical & Experimental Obstetrics and Gynecology, and Oncology. He has published 78 articles in reputed peer review journals. He is an editor of a book on ovarian cancer published in 2011.

Obstetrics & Gynecology: General Obstetrics & Gynecology Clinical Interests: - Genetics: Diagnosis and Therapy - Obstetrics and Gynecology/ Women's Health - Oncology - Gynecological Surgery

Dr. Samar Nahas, M.D., M.P.H. is an assistant clinical professor of gynecology and oncology at the University of California, Riverside School of Medicine. She practices at both the Riverside University Health System - Medical Center and Riverside Community Hospital. She previously worked as a member of the teaching faculty for medical students and residents at Trillium health partners hospital affiliated with the University of Toronto, she is also a member of the teaching faculty at the Laparoscopic Institute of Gynecologic Oncology in San Francisco. She is a member of the American College of Obstetrics and Gynecology, Royal College of Physician and Surgeons Canada, the Society of Gynecologic Oncology, and American association of Gynecologic Laparoscopists. She is fluent in English, Arabic and Persian.

Gynecologic Oncology, Innovative surgical techniques, Minimal invasive surgery, Laparoscopic surgical techniques

Michael A. Tainsky completed his PhD from Cornell University in 1977 and postdoctoral studies at the NCI in 1985. Dr. Tainsky has been at the rank of Professor with tenure since October, 1996. He came to WSU from The University of Texas M.D. Anderson Cancer Center in 1998. He has served as a KCI Program Leader for 14 years and Associate Director for Basic Research. His research identified p53 as the germline mutation in Li-Fraumeni Syndrome and novel germline mutations in hereditary ovarian cancer. He has identified a panel of autoantigen biomarkers for a blood test for the recurrence of OVCA that have homology to paraneoplastic antigens biomarkers for early detection and recurrence of ovarian cancer.

Ovarian Cancer

Alok De has received his PhD from University of Calcutta. He is a Research Biologist at Kansas City VA Medical Center. His research focuses on to use the extract of Emblica officinalis as an alternative or adjunct therapeutic agent in helping to fight ovarian cancer . He has published more than 45 papers in reputed journals. He has been serving as reviewers of many journals and as an Editorial Board Member of Cancer Cell and Micro environment

Ovarian cancer, Gynecologic Cancers